Section
Depression, anxiety, trauma, substance use, dementia and emerging treatments, as reported by clinical and research outlets.
846 articles · page 11 of 22 · Feb 25, 2026 – Mar 10, 2026
Archive summary Clinical
TONMYA (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults, was commercially launched in November 2025 Treatment with TONMYA ...
Archive summary Clinical
The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to hire a researcher and friend who wants the agency to add new warnings to…
Archive summary Clinical
Archive summary Clinical
Phase 3 pivotal program initiation for BPL-003 in treatment-resistant depression remains on track for Q2 2026 following successful End‐of‐Phase 2 meeting with the U.S.…
Archive summary Clinical
Recent changes in laws have made gambling widely accessible and popular. Uncontrolled gambling can have many kinds of consequences, some quite serious. A simple…
Archive summary Clinical
WASHINGTON, USA – The US Food and Drug Administration, on Thursday, issued a seeking public comment on potential new standards for in-home opioid disposal ...
Archive summary Clinical
A newly identified protein may hold the key to preventing diabetic blindness. Researchers discovered that LRG1 triggers the earliest damage in diabetic retinopathy by…
Archive summary Clinical
This common type of stress is becoming more prevalent in society for many reasons, experts say.
Archive summary Clinical
IFS is believed to be a useful treatment for PTSD. A new study provides the first research-based evidence of its efficacy.
Archive summary Clinical
People living with depression cannot just get over it. They need support, healing, and to discover the epicenter of their pain.
Archive summary Clinical
A coalition has urged the sports world to treat ACL injuries like brain injuries.
Archive summary Clinical
Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the first new FDA-approved…
Archive summary Clinical
NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Vistagen Therapeutics, Inc. (“Vistagen” or…
Archive summary Clinical
"If you're sober and in recovery, nothing's worth risking putting your sobriety at risk," said Lisa Smith, a former lawyer who struggled with drug and alcohol addiction…
Archive summary Clinical
A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders. An analysis of electronic…
Archive summary Clinical
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.)
Archive summary Clinical
Top FDA regulator Dr. Tracy Beth Hoeg is accused of bypassing standard recusal rules to advance a friend's push for new antidepressant warning labels.
Archive summary Clinical
WASHINGTON — The Food and Drug Administration's top drug regulator, Dr. Tracy Beth Hoeg, is working to hire a researcher and friend who wants the agency to add new…
Archive summary Clinical
The antidepressant review is the latest in a series of controversial topics taken up by Hoeg.
Archive summary Clinical
Archive summary Clinical
Researchers say the results must be confirmed in future randomized controlled trials.
Archive summary Clinical
Hope for Alzheimer's prevention emerges as scientists find existing seizure drug may stop disease progression if taken decades before symptoms appear.
Archive summary Clinical
Archive summary Clinical
Health and Human Services Secretary Robert F. Kennedy Jr. and Centers for Medicare and Medicaid Services Administrator Mehmet Oz announced an "Action for Progress"…
Archive summary Clinical
Archive summary Clinical
As alcohol misuse and opioid dependence continue to strain families across Los Angeles, addiction treatment providers are emphasizing the critical importance of…
Archive summary Clinical
Archive summary Clinical
A newly FDA-cleared treatment for major depressive disorder significantly accelerates symptom relief compared to traditional therapies. Accelerated Deep TMS (SWIFT) uses…
Archive summary Clinical
The FDA has approved zuranolone as the first oral medication indicated to treat postpartum depression (PPD), affecting 10-20 percent of new mothers. The medication…
Archive summary Clinical
Archive summary Clinical
Israeli biopharma company PsyRx is developing an innovative combination drug to address treatment-resistant depression (TRD), one of the most significant challenges in…
Archive summary Clinical
Depression affects approximately 5% of adults worldwide, and treatment-resistant depression represents a significant clinical challenge. About one-third of people with…
Archive summary Clinical
Archive summary Clinical
Public health researchers acknowledge the science on social media's impact on child mental health is still developing, with evidence showing both harmful and beneficial…
Archive summary Clinical
Psychologists are expanding the use of virtual reality in therapeutic settings, developing interventions that help patients develop stronger connections to their future…
Archive summary Clinical
The University of Cincinnati and UC Health have launched a new multidisciplinary addiction center to integrate research, clinical expertise, and education to improve…
Archive summary Clinical
BRENTWOOD, Tenn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- American Addiction Centers (AAC), a leading provider of addiction treatment, has launched AAC Together, a new alumni…
Archive summary Clinical
Archive summary Clinical
They’re prominent talking points for Health Secretary Robert F. Kennedy Jr.
Archive summary Clinical
They’re prominent talking points for Health Secretary Robert F. Kennedy Jr. and his top officials: Taking Tylenol while pregnant could be linked to autism.…